» Articles » PMID: 30070037

Correlation Between Radiomic Features Based on Contrast-enhanced Computed Tomography Images and Ki-67 Proliferation Index in Lung Cancer: A Preliminary Study

Overview
Journal Thorac Cancer
Date 2018 Aug 3
PMID 30070037
Citations 19
Authors
Affiliations
Soon will be listed here.
Abstract

Background: The purpose of the study was to investigate the association between radiomic features based on contrast-enhanced multidetector computed tomography (CT) and the Ki-67 proliferation index (PI) in patients with lung cancer.

Methods: One hundred and ten patients with lung cancer confirmed by surgical histology were retrospectively included. Radiomic features were extracted from preoperative contrast-enhanced chest multidetector CT images for each tumor using open-source three-dimensional Slicer software. Statistical analysis was performed to determine significant radiomic features serving as image predictors of Ki-67 status in lung cancer and to investigate the relationship between these features and Ki-67 PI.

Results: Higher Ki-67 expression was more common in men (P = 0.02) and patients with a smoking history (P = 0.01). Twelve radiomic features were significantly associated with Ki-67 status. Multivariate logistic regression analysis identified inverse variance, minor axis, and elongation as independent predictors of Ki-67 PI. There was a positive correlation between inverse variance, minor axis, elongation (P = 0.00, P = 0.02, and P = 0.14, respectively) and Ki-67 PI. The area under the curve to identify high Ki-67 status for inverse variance was 0.77 with a cutoff value of 0.47, which was significantly higher than for minor axis and elongation (P = 0.02 and P = 0.03, respectively).

Conclusion: Radiomic features based on contrast CT images, including inverse variance, minor axis, and elongation, can serve as noninvasive predictors of Ki-67 status in patients with lung cancer. Inverse variance could be superior to the other radiomic features to identify high Ki-67 status.

Citing Articles

Evaluation of radiomic feature harmonization techniques for benign and malignant pulmonary nodules.

Huchthausen C, Shi M, de Sousa G, Colen J, Shelley E, Larner J ArXiv. 2025; .

PMID: 39876938 PMC: 11774441.


CT-based radiomics for predicting Ki-67 expression in lung cancer: a systematic review and meta-analysis.

Luo X, Zheng R, Zhang J, He J, Luo W, Jiang Z Front Oncol. 2024; 14:1329801.

PMID: 38384802 PMC: 10879429. DOI: 10.3389/fonc.2024.1329801.


Deep Learning to Predict the Cell Proliferation and Prognosis of Non-Small Cell Lung Cancer Based on FDG-PET/CT Images.

Hu D, Li X, Lin C, Wu Y, Jiang H Diagnostics (Basel). 2023; 13(19).

PMID: 37835850 PMC: 10573026. DOI: 10.3390/diagnostics13193107.


CT radiomics model for predicting the Ki-67 proliferation index of pure-solid non-small cell lung cancer: a multicenter study.

Liu F, Li Q, Xiang Z, Li X, Li F, Huang Y Front Oncol. 2023; 13:1175010.

PMID: 37706180 PMC: 10497212. DOI: 10.3389/fonc.2023.1175010.


Radiomics nomogram for the prediction of Ki-67 index in advanced non-small cell lung cancer based on dual-phase enhanced computed tomography.

Sun H, Zhou P, Chen G, Dai Z, Song P, Yao J J Cancer Res Clin Oncol. 2023; 149(11):9301-9315.

PMID: 37204513 DOI: 10.1007/s00432-023-04856-2.


References
1.
Ishibashi N, Maebayashi T, Aizawa T, Sakaguchi M, Nishimaki H, Masuda S . Correlation between the Ki-67 proliferation index and response to radiation therapy in small cell lung cancer. Radiat Oncol. 2017; 12(1):16. PMC: 5237196. DOI: 10.1186/s13014-016-0744-1. View

2.
Gerdes J, Lemke H, Baisch H, Wacker H, Schwab U, STEIN H . Cell cycle analysis of a cell proliferation-associated human nuclear antigen defined by the monoclonal antibody Ki-67. J Immunol. 1984; 133(4):1710-5. View

3.
Yip S, Aerts H . Applications and limitations of radiomics. Phys Med Biol. 2016; 61(13):R150-66. PMC: 4927328. DOI: 10.1088/0031-9155/61/13/R150. View

4.
Lee G, Lee H, Park H, Schiebler M, van Beek E, Ohno Y . Radiomics and its emerging role in lung cancer research, imaging biomarkers and clinical management: State of the art. Eur J Radiol. 2016; 86:297-307. DOI: 10.1016/j.ejrad.2016.09.005. View

5.
Warth A, Cortis J, Soltermann A, Meister M, Budczies J, Stenzinger A . Tumour cell proliferation (Ki-67) in non-small cell lung cancer: a critical reappraisal of its prognostic role. Br J Cancer. 2014; 111(6):1222-9. PMC: 4453847. DOI: 10.1038/bjc.2014.402. View